{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:06Z","timestamp":1786988046259,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ejim.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T23:18:38Z","timestamp":1344640718000},"page":"745-754","source":"Crossref","is-referenced-by-count":91,"title":["Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"23","author":[{"given":"Hsin-Ta","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Sik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ovbiagele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Saver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2012.07.004_bb0005","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0010","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00726-008-0122-x","article-title":"Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells","volume":"36","author":"Curro","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejim.2012.07.004_bb0015","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.281.19.1817","article-title":"Homocysteine and risk of cardiovascular disease among postmenopausal women","volume":"281","author":"Ridker","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0025","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/01.CIR.0000131942.77635.2D","article-title":"Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese","volume":"109","author":"Iso","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0030","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jn\/124.7.1072","article-title":"Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction","volume":"124","author":"Jacob","year":"1994","journal-title":"J Nutr"},{"key":"10.1016\/j.ejim.2012.07.004_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1005373209964","article-title":"The natural history of vascular disease in homocystinuria and the effects of treatment","volume":"20","author":"Wilcken","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2012.07.004_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(99)07391-2","article-title":"Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial","volume":"355","author":"Vermeulen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.07.004_bb0050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/STROKEAHA.108.526798","article-title":"High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial","volume":"40","author":"Hodis","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2012.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.07.004_bb0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0065","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"CM","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0070","first-page":"CD006612","article-title":"Homocysteine lowering interventions for preventing cardiovascular events","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2012.07.004_bb0075","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2008"},{"key":"10.1016\/j.ejim.2012.07.004_bb0080","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ejim.2012.07.004_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2012.07.004_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"key":"10.1016\/j.ejim.2012.07.004_bb0100","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejim.2012.07.004_bb0105","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0110","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0735-1097(03)00485-6","article-title":"Secondary prevention with folic acid: effects on clinical outcomes","volume":"41","author":"Liem","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.ajkd.2008.06.016","article-title":"Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD","volume":"53","author":"Nanayakkara","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2012.07.004_bb0120","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/hrt.2005.074393","article-title":"Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease","volume":"92","author":"Rakhit","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2012.07.004_bb0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/oxfordjournals.aje.a008798","article-title":"Lowered risks of hypertension and cerebrovascular disease after vitamin\/mineral supplementation: the Linxian Nutrition Intervention Trial","volume":"143","author":"Mark","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0135","first-page":"PI37","article-title":"Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients","volume":"9","author":"Righetti","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejim.2012.07.004_bb0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000093680","article-title":"Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients","volume":"24","author":"Righetti","year":"2006","journal-title":"Blood Purif"},{"key":"10.1016\/j.ejim.2012.07.004_bb0145","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.07.004_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2003.02.001","article-title":"Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial","volume":"93","author":"Liem","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0155","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2004.035030","article-title":"Secondary prevention with folic acid: results of the Goes extension study","volume":"91","author":"Liem","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2012.07.004_bb0160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0165","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.07.004_bb0170","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0175","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","article-title":"Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events","volume":"11","author":"Vianna","year":"2007","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ejim.2012.07.004_bb0185","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0190","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/TP.0b013e31816b2602","article-title":"Long-term effect of folic acid therapy in heart transplant recipients: follow-up analysis of a randomized study","volume":"85","author":"Potena","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0195","first-page":"A 3642","article-title":"Blind comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial","volume":"106","author":"Baker","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0200","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(10)70187-3","article-title":"B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial","volume":"9","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2012.07.004_bb0205","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"303","author":"Armitage","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0210","doi-asserted-by":"crossref","first-page":"c6273","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2012.07.004_bb0215","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0218492309102494","article-title":"Folic acid-based intervention in non-ST elevation acute coronary syndromes","volume":"17","author":"Imasa","year":"2009","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.ejim.2012.07.004_bb0225","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0230","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/CIRCULATIONAHA.109.904672","article-title":"B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial","volume":"121","author":"Heinz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh023","article-title":"Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction","volume":"127","author":"Hassan","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.ejim.2012.07.004_bb0240","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.106.679084","article-title":"Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease","volume":"115","author":"Shirodaria","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0245","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.105.570846","article-title":"Improvement in stroke mortality in Canada and the United States, 1990 to 2002","volume":"113","author":"Yang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.108.816108","article-title":"Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study","volume":"119","author":"Lieb","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0255","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/CIRCULATIONAHA.105.570127","article-title":"Relationship between homocysteine and mortality in chronic kidney disease","volume":"113","author":"Menon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.07.004_bb0260","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","article-title":"Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease","volume":"98","author":"Mikael","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2012.07.004_bb0265","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2012.07.004_bb0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-9120(01)00187-4","article-title":"Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction","volume":"34","author":"Qujeq","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejim.2012.07.004_bb0275","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1996.03540070040028","article-title":"Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2012.07.004_bb0280","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T15:10:45Z","timestamp":1562080245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620512001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0953620512001793"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2012.07.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}